Updated Mar 04, 2021 | 13:24 IST
Morgan Stanley says Indian steel producers could increase prices supported by strong demand and higher international prices. It sees maximum upside potential in JSPL and SAIL. (Representational Image) | Photo Credit: iStock Images
Key Highlights
Morgan Stanley expects a price hike of US$10-15/t could come for flat products. For long products, secondary market prices have recovered by Rs 5,500/t from the bottom in early Feb-21
Post the Budget, steel prices stayed put which increased the discount to import parity price. Now with demand increasing, international prices improving there is scope for price hikes
Mumbai: Morgan Stanley believes Indian steel producers could increase prices supported by strong demand and higher international prices. The foreign brokerage sees maximum upside potential for JSPL & SAIL.
Johnson & Johnson COVID-19 vaccine backed by independent FDA committee
It could be authorized as soon as Saturday
Share this story
Jason Armond / Los Angeles Times via Getty Images
An independent committee of vaccine experts has unanimously recommended that the Food and Drug Administration authorize the Johnson & Johnson one-shot COVID-19 vaccine for people 18 and older, taking it one step closer to use in the United States. The FDA is expected to authorize the vaccine within days.
“I think it’s a relatively easy call,” said committee member Eric Rubin, an immunologist at the Harvard T.H. Chan School of Public Health. “It’s nice to have a single-dose vaccine.”
https://www.afinalwarning.com/485552.html (Natural News) Last December 2020, health experts from the
Food and Drug Administration (FDA) warned that Moderna’s coronavirus (COVID-19) vaccine has yet another negative side effect: Upon vaccination, people with cosmetic facial fillers experienced “swelling and inflammation.”
Most of the recipients of Moderna’s coronavirus vaccine have experienced mild side effects like headache, fatigue and pain at the injection site. Vaccine recipients who have had prior dermal fillers, but not Botox injections, may also experience temporary facial swelling.
Adverse effects of the Moderna vaccine
Data showed that the swelling was related to the COVID-19 vaccine. Back in December, FDA medical officer Dr. Rachel Zhang presented the findings at the Vaccines and Related Biological Products Advisory Committee on Moderna’s coronavirus vaccine.
Vaccine could cause swelling in those with cosmetic facial fillers but not damage them, experts say
Published: January 20, 2021 6:26 PM EST
Updated: January 20, 2021 6:32 PM EST
Recommended
Three women participating in Moderna COVID-19 vaccine clinical trials experienced symptoms they didn’t expect facial swelling. It’s because of something they do to improve their appearance.
“Both of these subjects had a prior history of dermal filler cosmetic injections in the cheeks. For one subject, it was about two weeks before vaccination, and for the other subject, it was about six months before vaccination,” said Dr. Rachel Zhang, an FDA Medical Officer, during Moderna’s Dec. 17 EUA meeting. “One subject had lip angioedema about two days after vaccination. And that subject also had a prior dermal injection in the lip.”